Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.

J, Häggström; A, Boswood; M, O'Grady; O, Jöns; S, Smith; S, Swift; M, Borgarelli; B, Gavaghan; JG, Kresken; M, Patteson; B, Ablad; CM, Bussadori; T, Glaus; A, Kovacević; M, Rapp; RA, Santilli; A, Tidholm; A, Eriksson; MC, Belanger; M, Deinert; CJ, Little; C, Kvart; A, French; M, Rønn-Landbo; G, Wess; AV, Eggertsdottir; ML, O'Sullivan; M, Schneider; CW, Lombard; J, Dukes-McEwan; R, Willis; A, Louvet; R, DiFruscia

doi:10.1111/j.1939-1676.2008.0150.x

Public

Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.

Shared by NobleBlocks on Jul 11, 2008 • 12:00 AM UTC

Authors:

Häggström J

Boswood A

O'Grady M

Abstract

Background Myxomatous mitral valve disease (MMVD) continues to be an important cause of morbidity and mortality in geriatric dogs despite conventional therapy.Hypothesis Pimobendan in addition to conventional therapy will extend time to sudden cardiac death, euthanasia for cardiac reasons, or treatm...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!